Palatin Technologies Inc (PTN)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 350,000
Cost of Revenue 0 0 0 169,908
Gross Profit 0 0 0 180,092
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,474,019 1,681,844 2,020,931 4,003,779
Operating Expenses 5,229,177 2,611,323 7,764,685 8,692,071
Operating Income -4,813,177 -2,611,323 -7,764,685 -8,342,071
Interest Expense -1,795 3,803 5,940 3,373
Income Before Tax -4,811,420 -2,442,482 -7,823,649 -8,250,430
Income Tax Expense 0 0 0 0
Net Income -4,811,420 -2,442,482 -7,823,649 -8,250,430
Per Share
EPS -0.18 -0.12 -0.39 -0.56
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 0 4,490,090 4,853,678 1,468,457 -188,597
Cost of Revenue 0 97,637 418,470 217,529 147,840
Gross Profit 0 4,392,453 3,775,538 1,250,928 -336,437
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 7,809,345 12,270,046 15,290,836 16,511,942 0
Operating Expenses 22,707,839 26,888,574 36,894,091 37,839,376 30,263,472
Operating Income -17,459,939 -22,496,121 -32,458,883 -36,588,448 -33,384,101
Interest Expense 15,025 17,114 20,013 29,682 23,440
Income Before Tax -17,307,349 -29,736,113 -28,711,740 -36,198,299 -33,596,495
Income Tax Expense 0 0 -4,674,999 -390,149 0
Net Income -17,307,349 -29,736,113 -24,036,741 -35,808,150 -33,596,495
Per Share
EPS -32.15 -2.02 -2.21 -3.75 -3.55
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 2,564,265 9,527,396 7,989,582 29,939,154
Short Term Investments 0 0 2,992,890 0
Net Receivables 29,468 0 2,915,760 1,780,020
Inventory 0 0 526,000 944,471
Total Current Assets 2,919,428 9,769,668 16,321,513 34,596,099
Property Plant Equipment 290,610 915,682 1,561,011 1,417,779
Goodwill and Intangibles 0 0 0 0
Total Assets 3,266,954 10,742,266 17,939,440 36,070,794
Liabilities
Account Payables 6,998,806 4,101,929 4,303,527 3,157,617
Short Term Debt 129,812 426,556 460,444 472,045
Total Current Liabilities 8,010,030 9,657,681 15,131,830 16,259,864
Long Term Debt 33,969 163,782 590,337 681,805
Total Liabilities 8,043,999 10,853,763 17,805,367 19,802,919
Shareholders Equity
Retained Earnings -459,073,899 -441,766,550 -415,535,583 -387,993,696
Total Shareholders Equity -4,777,045 -111,497 134,073 16,267,875
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 2,564,265 9,527,396 7,989,582 29,939,154 60,104,919
Short Term Investments 0 0 2,992,890 0 0
Net Receivables 29,468 0 2,915,760 1,780,020 1,580,443
Inventory 0 0 526,000 944,471 1,162,000
Total Current Assets 2,919,428 9,769,668 16,321,513 34,596,099 65,907,041
Property Plant Equipment 290,610 915,682 1,561,011 1,417,779 1,332,630
Goodwill and Intangibles 0 0 0 0 0
Total Assets 3,266,954 10,742,266 17,939,440 36,070,794 67,296,587
Liabilities
Account Payables 6,998,806 4,101,929 4,303,527 3,157,617 640,650
Short Term Debt 129,812 426,556 460,444 472,045 351,853
Total Current Liabilities 8,010,030 9,657,681 15,131,830 16,259,864 10,511,788
Long Term Debt 33,969 163,782 590,337 681,805 900,520
Total Liabilities 8,043,999 10,853,763 17,805,367 19,802,919 17,645,215
Shareholders Equity
Retained Earnings -459,073,899 -441,766,550 -415,535,583 -387,993,696 -351,795,397
Total Shareholders Equity -4,777,045 -111,497 134,073 16,267,875 49,651,372
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -17,307,349 -29,736,113 -27,541,887 -36,198,299
Depreciation & Amortization 258,917 339,075 288,331 126,668
Stock Based Compensation 1,382,281 1,872,698 1,410,917 2,505,538
Change in Working Capital 0 -3,406,846 392,272 3,439,421
Operating Cash Flow -21,306,637 -31,461,441 -28,419,001 -29,922,749
Investing Activities
Capital Expenditure 0 -42,526 -433,927 -261,374
Investments 0 -42,526 -433,927 -261,374
Investing Cash Flow 3,130,000 12,450,364 -3,426,817 -261,374
Financing Activities
Debt Repayment 0 -106,392 -100,922 -56,463
Common Stock Issued/Repurchased 7,960,765 14,666,042 9,997,090 -205,179
Dividends Paid 0 0 0 -221,311
Financing Cash Flow 11,213,506 20,548,891 9,896,246 18,358
Summary
Free Cash Flow -21,306,637 -31,503,967 -28,852,928 -30,184,123
Net Change in Cash -6,963,131 1,537,814 -21,949,572 -30,165,765
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income -17,307,349 -29,736,113 -27,541,887 -36,198,299 -33,596,495
Depreciation & Amortization 258,917 339,075 288,331 126,668 51,121
Stock Based Compensation 1,382,281 1,872,698 1,410,917 2,505,538 3,168,656
Change in Working Capital 0 -3,406,846 392,272 3,439,421 -11,567,991
Operating Cash Flow -21,306,637 -31,461,441 -28,419,001 -29,922,749 -22,647,991
Investing Activities
Capital Expenditure 0 -42,526 -433,927 -261,374 -5,722
Investments 0 -42,526 -433,927 -261,374 -5,722
Investing Cash Flow 3,130,000 12,450,364 -3,426,817 -261,374 -5,722
Financing Activities
Debt Repayment 0 -106,392 -100,922 -56,463 0
Common Stock Issued/Repurchased 7,960,765 14,666,042 9,997,090 -205,179 0
Dividends Paid 0 0 0 -221,311 0
Financing Cash Flow 11,213,506 20,548,891 9,896,246 18,358 -93,638
Summary
Free Cash Flow -21,306,637 -31,503,967 -28,852,928 -30,184,123 -22,653,713
Net Change in Cash -6,963,131 1,537,814 -21,949,572 -30,165,765 -22,747,351